Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
American Journal of Hematology|June 26, 2024
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Diego Villa Clé, Jin Seok Kim, et al.Cancer|October 6, 2023
Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemiaFabio Efficace, Francesco Cottone, Betina Yanez, et al.American Journal of Hematology|August 11, 2025
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter ExperienceBruno Fattizzo, Giacinto Luca Pedone, Elisabetta Metafuni, et al.British Journal of Haematology|January 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort studyMassimo Breccia, Valentina Giai, Tiziana Rosso, et al.Mechanisms of Ageing and Development|June 13, 2012
Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartmentChiara Lobetti-Bodoni, Dario Ferrero, Elisa Genuardi, et al.Annals of Hematology|November 27, 2023
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinibOlga Mulas, Elisabetta Abruzzese, Luigiana Luciano, et al.Cancer|October 15, 2025
Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS studyAnna Sicuranza, Paola Pacelli, Adele Santoni, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2021
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic SyndromesGuillermo Garcia-Manero, Valeria Santini, Antonio Almeida, et al.Journal of Clinical Medicine|November 20, 2020
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after DiscontinuationMatteo Dragani, Giovanna Rege Cambrin, Paola Berchialla, et al.The New England Journal of Medicine|December 28, 2020
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First RemissionAndrew H Wei, Hartmut Döhner, Christopher Pocock, et al.Pageof 5